Molecular and Cellular Bioengineering and Nanobiotechnology
The research seeks to understand and harness biological processes from molecular to cellular levels for biocatalysis, biotherapeutics, and disease prevention. Topics include development of microbial fuel cells for production of electricity and hydrogen (Frymier), redesign of natural protein machinery for biosensors and biotherapeutics (Boder), application of computational methods to study fundamental processes in cell biology and immunology (Abel), understanding lipid formation and distribution in cells, development of nanotechnologies to treat cancers in obese patients (Dalhaimer), and development of Virulent Pathogen Resistance (ViPaRe) technology for effective antimicrobials (Trinh).
Trinh Tackles Cells at Their Core
Ferguson Faculty Fellow Cong Trinh’s research combines a wide range of math, science, and computing with the goal to reduce lag times in identifying and responding to diseases.
All Data All The Time for Abel
Associate Professor Steven Abel and his group create physical or mathematical models, helping researchers gain a better understanding of how cells behave.
Faculty Feature: Paul Dalhaimer
Associate Professor Paul Dalhaimer is researching the molecular mechanisms governing the onsets of obesity and type 2 diabetes.
- Elongated PEO-based nanoparticles bind the high-density lipoprotein (HDL) receptor scavenger receptor class B I (SR-BI)
- Endogenous Carbohydrate Esterases of Clostridium Thermocellum are Identified and Disrupted for Enhanced Isobutyl Acetate Production from Cellulose